A Study Evaluating the Safety and Efficacy of AUR107 in Patients With Relapsed Advanced Malignancies (SHAKTI-1)
Aurigene Discovery Technologies Limited
Aurigene Discovery Technologies Limited
University of Pittsburgh
Genentech, Inc.
National Cancer Institute (NCI)
Jazz Pharmaceuticals
Bayer
Seagen Inc.
Alliance for Clinical Trials in Oncology
Pfizer
AstraZeneca
Imperial College London
Eli Lilly and Company
SystImmune Inc.
Mayo Clinic
UMC Utrecht
Neonc Technologies, Inc.
ViroMissile, Inc.
Washington University School of Medicine
Essen Biotech
Baylor College of Medicine
Daiichi Sankyo
University of Nebraska
Adela, Inc
Phrontline Biopharma
Var2 Pharmaceuticals
Tanabe Pharma America, Inc.
Mayo Clinic
Massive Bio, Inc.
University of Erlangen-Nürnberg Medical School
Dana-Farber Cancer Institute
Guardant Health, Inc.
Jonsson Comprehensive Cancer Center
Medicenna Therapeutics, Inc.
Marengo Therapeutics, Inc.
ModeX Therapeutics, An OPKO Health Company
Cancer Research UK
Columbia University
Chinese University of Hong Kong
Stanford University
Singlera Genomics Inc.
European Organisation for Research and Treatment of Cancer - EORTC
Charite University, Berlin, Germany
Hospices Civils de Lyon
University Hospital Tuebingen